<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02918487</url>
  </required_header>
  <id_info>
    <org_study_id>OI - 004 - 2016</org_study_id>
    <nct_id>NCT02918487</nct_id>
  </id_info>
  <brief_title>Role of Herbs in the Management of Asthma</brief_title>
  <official_title>Role of Breathe Free® in the Management of Bronchial Asthma- A Randomized Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Organic India</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Organic India</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this trial is to study the effect of a polyherbal capsule containing four herbs:
      Inula racemosa, Ocimum sanctum, Terminalia Belerica and Piperum longum in the treatment of
      bronchial asthma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized placebo controlled double blind trial. Four herbs that have proven efficacy on
      bronchial asthma will be given. Equally matched placebo will be given randomly to patients.
      Each arm active herbs and placebo will be compared against the Formoterol+Fluticasone Single
      maintenance and reliever therapy(SMART) and conventional therapy. All the parameters of
      Bronchial Asthma(BA) will be compared between the randomized groups.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">May 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with 15% increase in forced expiratory volume(FEV1) from baseline</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with 50 L/min peak expiratory flow rate(PEFR) from baseline</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with frequency of asthma exacerbation per week</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Bronchial Asthma</condition>
  <arm_group>
    <arm_group_label>Active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>[Formoterol + Fluticasone] Single maintenance and reliever therapy(SMART) and Active polyherbal capsule</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>[Formoterol + Fluticasone] conventional along with inert similar looking placebo capsules</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Polyherbal</intervention_name>
    <description>Each capsule contains four herbs: Inula racemosa, Ocimum sanctum, Terminalia Belerica and Piperum longum</description>
    <arm_group_label>Active</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Breathe Free</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Inactive compound that is similar looking as the intervention</description>
    <arm_group_label>Active</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults aged ≥ 18 years.

          -  History of asthma documented by a physician for at least 6 months

          -  Patients on steroid therapy for at least 4 weeks.

          -  If not on steroid therapy, patient and physician must be willing for 4 weeks run in on
             steroid therapy.

          -  The subject agrees to participate in the study

        Exclusion Criteria:

          -  Any one of the following

               -  Acute illness (such as cold, flu, etc.) within one week before the administration
                  of study drug

               -  Abnormal hepatic and renal function

               -  Pregnant, attempting to conceive, or lactating women

               -  Current or former employees of organic India

               -  Participating in another clinical trial with an active intervention or drug or
                  device with last dose taken within 60 days.

               -  Physician uncomfortable with patient compliance to treatments or follow up.

               -  Non-compliance to tobacco cessation therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Alben Sigamani</last_name>
    <role>Principal Investigator</role>
    <affiliation>Narayana Hrudayalaya Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mazumdar Shaw Mutispeciality Hospital</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2016</study_first_submitted>
  <study_first_submitted_qc>September 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2016</study_first_posted>
  <last_update_submitted>April 10, 2018</last_update_submitted>
  <last_update_submitted_qc>April 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

